BSECompany UpdateESG6d ago
Anupam Rasayan India Ltd
The Company has informed the Exchange about intimation of ESG Rating.
Anupam Rasayan India Ltd has received an ESG rating of 'Crisil ESG 62' and a Core ESG rating of 'Crisil Core ESG 63 (Strong)' from Crisil ESG Ratings & Analytics Limited.
BSEInsider Trading / SASTPledge8 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Anupam Rasayan India Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the pledging of shares by Catalyst Trusteeship Ltd, a debenture trustee, on behalf of debenture holders.
BSECompany UpdateRegulatory7 Oct 2026
Anupam Rasayan India Ltd
Confirmation of Non-Applicability of Regulation 74(5) of SEBI DP Regulations, for the quarter ended September 30, 2026.
Anupam Rasayan India Ltd has confirmed that Regulation 74(5) of SEBI DP Regulations, 2018 is not applicable to the company for the quarter ended September 30, 2026, as the entire holding of the company's shares are in dematerialized form.
BSEInsider Trading / SASTPledge6 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 06, 2026 for Mona Anandbhai Desai
Anupam Rasayan India Ltd's promoter, Mona Anandbhai Desai, has submitted a disclosure under SEBI's SAST Regulations, updating the creation and release of pledges on shares. The disclosure includes reasons for encumbrance and details of release of pledge on shares.
BSEInsider Trading / SASTPledge6 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 06, 2026 for Mona Anandbhai Desai
Anupam Rasayan India Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation and release of pledges on shares held by Mona Anandbhai Desai, a promoter of the company.
BSEInsider Trading / SASTPledge6 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Anupam Rasayan India Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the pledging of shares by Catalyst Trusteeship Ltd, a Debenture Trustee, on behalf of Debenture Holders.
BSEInsider Trading / SASTPledge5 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2026 for Rehash Industrial and Resins Chemicals Pvt Ltd
Anupam Rasayan India Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Rehash Industrial and Resins Chemicals Private Ltd, a promoter of the company, regarding the release of pledge on 50,00,000 equity shares held by them.
BSEInsider Trading / SASTPledge5 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2026 for Mona Anandbhai Desai
Anupam Rasayan India Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of a pledge on 14,60,625 equity shares of the company by Mona Anandbhai Desai, a promoter of the company, on September 23, 2026, as security for the due payment and discharge of debt arising from the issuance and allotment of non-convertible debentures by the company's wholly owned subsidiary.
BSEInsider Trading / SASTPledge5 Oct 2026
Anupam Rasayan India Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 01, 2026 for Anand Sureshbhai Desai & Shraddha Anand Desai
Anupam Rasayan India Ltd's promoter, Anand Sureshbhai Desai, has created pledges on 31,40,000 and 39,01,160 shares, and Shraddha Anand Desai has created a pledge on 50,00,000 shares, for security and repayment of loans.
BSEAGM/EGM1 Oct 2026
Anupam Rasayan India Ltd
Submission of Scrutinizer''s Report along with e-voting results of 23rd Annual General Meeting held on September 30, 2026.
Anupam Rasayan India Ltd has submitted the Scrutinizer's Report along with e-voting results of its 23rd Annual General Meeting held on September 30, 2026, confirming the passing of resolutions with requisite majority.
BSECompany UpdateM&A30 Sept 2026
Anupam Rasayan India Ltd
Update on disclosure dated 28 September 2026 on the intimation of acquisition of equity shares of Bliss GVS Pharma Limited.
Anupam Rasayan India Ltd has clarified its earlier disclosure regarding the acquisition of equity shares of Bliss GVS Pharma Limited, correcting typographical errors and providing details on the consummation of the transaction.
BSEInsider Trading / SASTPledge30 Sept 2026
Anupam Rasayan India Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 30, 2026 for Anand Sureshbhai Desai
Anupam Rasayan India Ltd's promoter Anand Sureshbhai Desai has released a pledge of 33,40,000 shares, which was created for the due payment and discharge of debt arising from the issuance of non-convertible debentures.
BSEAGM/EGM30 Sept 2026
Anupam Rasayan India Ltd
Submission of proceedings of the 23rd Annual General Meeting of members of the Company held on September 30, 2026.
Anupam Rasayan India Ltd has submitted the proceedings of its 23rd Annual General Meeting (AGM) held on September 30, 2026, through Video Conferencing. The meeting was attended by the Chairperson, Directors, and Key Managerial Personnel, and the necessary quorum was present. The AGM was conducted in accordance with the circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.
BSEInsider Trading / SASTPledge30 Sept 2026
Anupam Rasayan India Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Catalyst Trusteeship Limited has acquired 1,03,61,785 equity shares of Anupam Rasayan India Limited, representing 9.10% of the company's total voting capital, through a pledge of shares in favor of Catalyst Trusteeship Limited as Debenture Trustee on behalf of Debenture holders.
BSECompany UpdateM&A28 Sept 2026
Anupam Rasayan India Ltd
Acquisition of equity shares of Bliss GVS Pharma Limited.
Anupam Rasayan India Ltd has acquired 22,50,000 equity shares of Bliss GVS Pharma Limited, representing 47.95% of the equity share capital of Bliss, through an on-market transaction. The acquisition is in addition to the 1,669 equity shares acquired through the open offer, making the total holding of Anupam Rasayan India Ltd and its partner 50.07% of the equity share capital of Bliss.
BSEInsider Trading / SAST28 Sept 2026
Anupam Rasayan India Ltd
The trading window of the Company for dealing in the securities shall remain closed from Thursday, 01 October 2026 till the end of the 48 hours after declaration of unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and half-year ended September 30, 2026.
Anupam Rasayan India Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of unaudited Financial Results for the quarter and half-year ended September 30, 2026, in accordance with SEBI PIT Regulations.
BSECompany Update▲ PositiveM&A28 Sept 2026
Anupam Rasayan India Ltd
Submission of Press Release titled Anupam Rasayan concludes acquisition of Bliss GVS Pharma, makes third strategic step towards building an Integrated Global Pharma Platform.
Anupam Rasayan India Ltd has completed the acquisition of Bliss GVS Pharma, marking its third strategic step towards building an integrated global pharma platform. The acquisition strengthens its presence in finished pharmaceutical formulations and complements its expertise in key starting materials, intermediates, and specialty chemicals.
BSECompany UpdateOrder Win24 Sept 2026
Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed BSE about Intimation on Agreements.
Anupam Rasayan India Limited has informed BSE about Intimation on Agreements.
BSECompany UpdateOrder Win24 Sept 2026
Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed BSE about Intimation on Agreements.
Anupam Rasayan India Limited has informed BSE about Intimation on Agreements.
BSECompany UpdateOrder Win24 Sept 2026
Anupam Rasayan India Limited
Anupam Rasayan India Limited has informed BSE about Intimation on Agreements.
Anupam Rasayan India Limited has informed BSE about Intimation on Agreements.